More on APLS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.7 Score)
- Holders

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Apellis Pharmaceuticals (NQ:APLS)
Delayed: 20.07 -0.08 (0.4%)
Prev. Close $20.15  
Open$20.21 
52 Wk High$0.01 
52 Wk Low$0.00 
Day High$20.39 
Day Low$19.75 
P/E N/A  
EPS$0.00 
Volume1,627,208 

Friends, Peers and Foes (?): BBIO, EYPT, AEIS, AHR, AMRX (more...)

Mar 5, 2026 07:36 AM Apellis Pharmaceuticals (APLS) PT Raised to $37 at JPMorgan
Mar 5, 2026 06:41 AM Apellis Pharmaceuticals (APLS) PT Raised to $20 at Mizuho
Mar 3, 2026 04:09 PM Form 4 Apellis Pharmaceuticals, For: Feb 27 Filed by: Dolsten Mikael
Mar 3, 2026 04:08 PM Form 3 Apellis Pharmaceuticals, For: Mar 02 Filed by: Dolsten Mikael
Mar 2, 2026 07:05 AM Form 8-K Apellis Pharmaceuticals, For: Feb 27
Mar 2, 2026 07:00 AM Apellis adds former Pfizer executive Dolsten to board of directors
Mar 2, 2026 07:00 AM Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Feb 26, 2026 06:41 AM Apellis Pharmaceuticals (APLS) PT Raised to $20 at Mizuho
Feb 25, 2026 09:07 AM Apellis Pharmaceuticals (APLS) PT Lowered to $21 at RBC Capital
Feb 25, 2026 06:40 AM Apellis Pharmaceuticals (APLS) PT Raised to $48 at H.C. Wainwright
View All Articles

Entities mentioned with APLS

View All Entities